Diabetes Type II Clinical Trial
Official title:
Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices (Short Title: TITRATE)
The aim of the study is to observe patients with Type 2 Diabetes on basal insulin alone or basal insulin with oral agents can be efficiently and safely started with meal time insulin using U100 rapid acting insulin analog and V-Go® Disposable Insulin Delivery Device (V-Go) using one of two dose titration algorithms to achieve improved A1C at 4 months.
This study addresses the informational needs of Primary Care Physicians with regard to providing insulin dosing and titration information utilizing a V-Go disposable insulin delivery device. We look to compare two treatment arms of insulin dosing and titration in patients with Type 2 insulin-dependent diabetes - a fixed dose titration arm, and an arm where 50% of the insulin dose is given at the largest meal of the day. This study will provide practical information on glycemic control, dose requirements and safety in patients with Type 2 diabetes on basal insulin with or without oral anti-diabetic agents who are being primarily managed in the primary care office. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01713764 -
A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics
|
Phase 2 | |
Completed |
NCT01121315 -
A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care
|
N/A | |
Completed |
NCT02773095 -
Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative
|
N/A | |
Completed |
NCT02184455 -
Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment
|
Phase 1 | |
Completed |
NCT02326129 -
Novel Biomarker for Development of T2D
|
||
Not yet recruiting |
NCT02074540 -
The Influence of Health Beliefs and Uncertainty on Diabetes Type II Patient Compliance
|
N/A |